InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd (ASX:IRX) – a company which develops inhaled drug-device treatments for…
Inhalerx Limited (ASX:IRX)
About Inhalerx Limited
Key Information
IRX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 15/11/2024 | Price Sensitive PS Ethics Approval for Phase 2 Clinical Trial of IRX-211 | 176.1KB | 893 |
| 14/11/2024 | Change in substantial holding - Cannvalate | 176.63KB | 370 |
| 31/10/2024 | Price Sensitive PS Sep24 Appendix 4C Cash Flow Report | 229.5KB | 233 |
| 31/10/2024 | Price Sensitive PS Sep24 Quarterly Activities Report | 254.76KB | 252 |
| 29/10/2024 | General Meeting - Access Letter | 115.89KB | 144 |
| 29/10/2024 | Notice of General Meeting | 291.65KB | 137 |
| 29/10/2024 | General Meeting - Sample Proxy | 192.29KB | 145 |
| 28/10/2024 | Change in substantial holding | 1.02MB | 275 |